Biopharma Manufacturing in MA
Massachusetts is a leader in biopharmaceutical manufacturing because of its unsurpassed workforce, a life sciences ecosystem rich in supportive services and expertise, and government policies that promote manufacturing operations.
DID YOU KNOW?
Massachusetts is at the center of the region with the greatest biologics manufacturing capacity in the world – with 600,000 liters of mammalian cell culture manufacturing capacity (in use and in validation).
Of the top 11 biopharma manufacturing states, Massachusetts was one of just four which added manufacturing jobs in the last decade.
Recently, Bristol Myers Squibb, Genzyme, and Shire are among the companies that have made major investments in commercial biopharma manufacturing facilities in Massachusetts.
MassBio is a not-for-profit organization committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives.
Founded in 1985, MassBio represents over 650 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
- November 16, 2015 Symposium highlights CROs and CMOs, the unsung heroes of biotech: BBJ, 11/11/2015
- November 6, 2015 Science Takes Center Stage for MA High School Students
- November 2, 2015 Four New Companies Debut at MassCONNECT Showcase
- October 29, 2015 Life Science Real Estate Developer King Street Properties to Break Ground on a New $45.5 Million Building at 115 Hartwell Avenue in The Hartwell Innovation Campus in Lexington, Massachusetts
- October 20, 2015 National Tay-Sachs & Allied Diseases to Honor Robert K. Coughlin, President and Chief Executive Officer of Massachusetts Biotechnology Council, at Benefit Event